LEADER 01125nam--2200385---450- 001 990003561870203316 005 20140416093646.0 010 $a978-83-7363-926-3 035 $a000356187 035 $aUSA01000356187 035 $a(ALEPH)000356187USA01 035 $a000356187 100 $a20110908d2009----km-y0itay50------ba 101 $ager 102 $aPOL 105 $a||||||||001yy 200 1 $a"Und ich brauch doch so schrecklich freude"$eFrauentopoi im werk von Anna Seghers$fMa?gorzata Dubrowska 210 $aLublin$cWydawnicto KUL$d2009 215 $a294 p.$d24 cm 410 0$12001 454 1$12001 461 1$1001-------$12001 600 1 $aSeghers, Anna$xStudi 676 $a830 700 1$aDUBROWSKA,$bMa?gorzata$0610502 801 0$aIT$bsalbc$gISBD 912 $a990003561870203316 951 $aII.3.B.492$b475 DIPSUM 959 $aBK 969 $aDSLL 979 $aDSLL$b90$c20110908$lUSA01$h1213 979 $aMARANO$b90$c20140416$lUSA01$h0935 979 $aMARANO$b90$c20140416$lUSA01$h0936 996 $a"Und ich brauch doch so schrecklich freude"$91117148 997 $aUNISA LEADER 04926nam 2200961 450 001 9910821772403321 005 20230807204928.0 010 $a0-520-96081-5 024 7 $a10.1525/9780520960817 035 $a(CKB)2670000000594516 035 $a(EBL)1939109 035 $a(SSID)ssj0001421539 035 $a(PQKBManifestationID)12606365 035 $a(PQKBTitleCode)TC0001421539 035 $a(PQKBWorkID)11424109 035 $a(PQKB)10525965 035 $a(MiAaPQ)EBC1939109 035 $a(DE-B1597)520704 035 $a(OCoLC)903206522 035 $a(DE-B1597)9780520960817 035 $a(Au-PeEL)EBL1939109 035 $a(CaPaEBR)ebr11020999 035 $a(CaONFJC)MIL727581 035 $a(EXLCZ)992670000000594516 100 $a20150227h20152015 uy 0 101 0 $aeng 135 $aur|nu---|u||u 181 $ctxt 182 $cc 183 $acr 200 10$aPurchasing medical innovation $ethe right technology, for the right patient, at the right price /$fJames C. Robinson 210 1$aOakland, California :$cUniversity of California Press,$d2015. 210 4$dİ2015 215 $a1 online resource (183 p.) 300 $aIncludes index. 311 0 $a0-520-28166-7 311 0 $a1-322-96299-5 327 $tFront matter --$tContents --$tList of Illustrations --$tAcknowledgments --$tIntroduction --$t1. Regulatory Access to the Market --$t2. Insurance Coverage and Reimbursement --$t3. Methods of Payment for Medical Technology --$t4. The Hospital as Purchaser --$t5. Organizational Capabilities for Technology Purchasing --$t6. The Patient as Purchaser --$t7. Implications for the Medical Technology Industry --$tNotes --$tIndex 330 $aInnovation in medical technology generates a remarkable supply of new drugs, devices, and diagnostics that improve health, reduce risks, and extend life. But these technologies are too often used on the wrong patient, in the wrong setting, or at an unaffordable price. The only way to moderate the growth in health care costs without undermining the dynamic of medical innovation is to improve the process of assessing, pricing, prescribing, and using new technologies. Purchasing Medical Innovation analyzes the contemporary revolution in the purchasing of health care technology, with a focus on the roles of the Food and Drug Administration (FDA), Medicare and private health insurers, physicians and hospitals, and consumers themselves. The FDA is more thoroughly assessing product performance under real-world conditions as well as in laboratory settings, accelerating the path to market for breakthroughs while imposing use controls on risky products. Insurers are improving their criteria for coverage and designing payment methods that reward efficiency in the selection of new treatments. Hospitals are aligning adoption of complex supplies and equipment more closely with physicians' preferences for the best treatment for their patients. Consumers are becoming more engaged and financially accountable for their health care choices. This book describes both the strengths and deficiencies of the current system of purchasing and highlights opportunities for buyers, sellers, and users to help improve the value of medical technology: better outcomes at lower cost. 606 $aMedical technology$xCost control 606 $aMedical innovations$xCost control 606 $aMedical care, Cost of 606 $aMedical care$xCost control 606 $aHealth care reform 606 $aHealth insurance 610 $aartificial heart valves. 610 $acost of medical technology. 610 $acost of medical treatment. 610 $aeconomics of healthcare. 610 $ahealth care costs. 610 $ahealth care reform. 610 $ahealth insurance. 610 $ahealth policy. 610 $ahip replacement. 610 $aimproving patient care. 610 $ainnovative medical care. 610 $ainsurance coverage for medical care. 610 $ajoint replacement. 610 $aknee replacement. 610 $amedical care. 610 $amedical costs. 610 $amedical economics. 610 $amedical innovation. 610 $amedical market access. 610 $amedical technology industry. 610 $amedical technology. 610 $apatient care. 610 $aprice of medical technology. 615 0$aMedical technology$xCost control. 615 0$aMedical innovations$xCost control. 615 0$aMedical care, Cost of. 615 0$aMedical care$xCost control. 615 0$aHealth care reform. 615 0$aHealth insurance. 676 $a610.28 700 $aRobinson$b James C$g(James Claude),$f1953-$01100077 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821772403321 996 $aPurchasing medical innovation$93986770 997 $aUNINA LEADER 02289nam 2200457z- 450 001 9910557396303321 005 20220111 035 $a(CKB)5400000000041934 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76869 035 $a(oapen)doab76869 035 $a(EXLCZ)995400000000041934 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aQualitative Analysis of Food Products 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (76 p.) 311 08$a3-0365-1846-0 311 08$a3-0365-1845-2 330 $aQualitative control and analysis of food products is a requirement for food industries, both in terms of quality assurance and food safety management systems. Analysis of foods is continuously requiring the development of more robust, efficient, sensitive, and cost-effective analytical methodologies to guarantee the safety, quality, authenticity, and traceability of foods in compliance with legislation and consumers' demands.Different analyses include microbiological and chemical analyses, from simple to complex, from old to modern technologies. Hence, fundamental and/or state-of-the-art methods of the development, optimization, and practical implementation in routine laboratories, and validation of these methods for the monitoring of food safety and quality, are employed. Methodologies for food microbial contaminants, food chemistry and toxicology, food quality, food authenticity, and food traceability have been presented and discussed in this Special Issue. 606 $aTechnology: general issues$2bicssc 610 $aauthenticity 610 $achemical 610 $achemometrics 610 $acontrol 610 $afood 610 $aFoodomics 610 $amicrobiological 610 $aquality 610 $asafety 610 $astatistical 615 7$aTechnology: general issues 700 $aVarzakas$b Theodoros$4edt$01126746 702 $aVarzakas$b Theodoros$4oth 906 $aBOOK 912 $a9910557396303321 996 $aQualitative Analysis of Food Products$93023588 997 $aUNINA